621 North Hall Street, Dallas, TX, 75226 · (214) 820-0600
Beds
56
FY 2024
Star rating
5 of 5
Patient survey: 4 of 5
Net patient revenue
$283.7M
FY 2024
Net income
$90.6M
Patient care margin 30.5%
Discharges
2,820
Occupancy 51.4%
Clinicians
568
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2024 | $283.7M | $197.1M | 30.5% | $90.6M | 2,820 | $4.4M | 31.9% | 1.3% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for heart attack patients | 10.2% | US median 11.8% |
| Death rate for heart failure patients | 9.3% | US median 11% |
| Hospital-wide death rate within 30 days | 3.7% | US median 3.9% |
| Readmission rate after a heart attack | 15.4% | US median 14.4% |
| Readmission rate for heart failure | 21.7% | US median 21.3% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2023 | $255.0M | $178.4M | 30.0% | $80.4M | 2,813 | $4.6M | 34.4% | 0.4% |
| 2022 | $241.8M | $163.1M | 32.5% | $81.2M | 2,623 | $4.3M | 36.9% | 0.0% |
| 2021 | $220.0M | $149.5M | 32.0% | $74.7M | 2,550 | $4.4M | 38.4% | 0.7% |
| 2020 | $200.9M | $147.3M | 26.7% | $60.4M | 2,284 | $4.2M | 42.0% | 0.6% |
| Serious complications (patient safety composite) | 0.83 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.00 | US median 0.28 |
| Doctors always communicated well | 84% | US median 79% |
| Nurses always communicated well | 87% | US median 80% |
| Patient survey summary star rating | 4 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 66% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 84% | US median 72% |
| Room and bathroom always clean | 83% | US median 73% |
| Patients who would definitely recommend the hospital | 87% | US median 71% |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 15% | US median 15% |
| Healthcare workers given the flu vaccine | 95% | US median 79% |
| DRG 267 ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITHOUT MCC |
| 88 |
| $187,920.47 |
| $31,809.81 |
| $40,566.75 |
| DRG 287 CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATHETERIZATION WITHOUT MCC | 50 | $47,711.72 | $5,426.10 | $7,565.66 |
| DRG 291 HEART FAILURE AND SHOCK WITH MCC | 45 | $37,715.89 | $6,556.78 | $10,022.34 |
| DRG 252 OTHER VASCULAR PROCEDURES WITH MCC | 43 | $75,217.51 | $20,896.95 | $29,696.95 |
| DRG 322 PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITHOUT MCC | 42 | $108,850.83 | $10,043.62 | $12,904.99 |
| DRG 321 PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITH MCC OR 4+ ARTERIES/ | 37 | $128,649.32 | $17,776.97 | $22,190.93 |
| DRG 286 CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATHETERIZATION WITH MCC | 33 | $67,859.09 | $11,328.24 | $17,632.75 |
| DRG 309 CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH CC | 30 | $14,949.30 | $3,445.43 | $5,247.13 |
| DRG 229 OTHER CARDIOTHORACIC PROCEDURES WITHOUT MCC | 30 | $134,607.53 | $19,301.27 | $26,680.82 |
| DRG 036 CAROTID ARTERY STENT PROCEDURES WITHOUT CC/MCC | 27 | $62,300.63 | $11,519.00 | $13,372.42 |
| DRG 310 CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT CC/MCC | 23 | $12,459.96 | $2,196.61 | $3,433.11 |
| DRG 269 AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON WITHOUT MCC | 17 | $127,347.71 | $27,741.12 | $34,069.62 |
| DRG 035 CAROTID ARTERY STENT PROCEDURES WITH CC | 17 | $70,457.29 | $14,405.88 | $17,302.50 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5191 Level 1 Endovascular Procedures | 807 | 804 | $2,044.71 | $2,207.96 |
| APC 5213 Level 3 Electrophysiologic Procedures | 380 | 370 | $19,374.53 | $21,117.37 |
| APC 5193 Level 3 Endovascular Procedures | 374 | 350 | $8,102.34 | $8,873.86 |
| APC 5223 Level 3 Pacemaker and Similar Procedures | 188 | 187 | $7,928.28 | $8,569.01 |
| APC 5192 Level 2 Endovascular Procedures | 152 | 145 | $3,990.30 | $4,338.16 |
| APC 5183 Level 3 Vascular Procedures | 109 | 106 | $2,201.13 | $2,405.01 |
| APC 5194 Level 4 Endovascular Procedures | 104 | 97 | $14,115.94 | $14,606.35 |
| APC 5184 Level 4 Vascular Procedures | 90 | 77 | $3,896.40 | $3,945.82 |
| APC 5232 Level 2 ICD and Similar Procedures | 87 | 87 | $27,079.38 | $29,374.70 |
| APC 5224 Level 4 Pacemaker and Similar Procedures | 70 | 70 | $15,858.25 | $17,051.61 |
| APC 5222 Level 2 Pacemaker and Similar Procedures | 68 | 68 | $6,084.06 | $6,513.82 |
| APC 5361 Level 1 Laparoscopy and Related Services | 21 | 18 | $3,940.10 | $4,357.80 |
Reported payments to this teaching hospital
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Baylor Scott & White Heart & Vascular Hospital - Dallas is a for-profit short-term acute care hospital in Dallas, TX with 56 beds, part of Baylor Scott & White Health and a 5-star overall rating.
Baylor Scott & White Heart & Vascular Hospital - Dallas in Dallas, TX has 56 beds (fiscal year 2024 cost report); 61 beds are certified for Medicare. It discharged 2,820 inpatients that year, with 51.4% of its beds in use on average.
In fiscal year 2024 (ending 2024-06-30), Baylor Scott & White Heart & Vascular Hospital - Dallas reported net patient revenue of $283.7M and operating expenses of $197.1M, a margin on patient care of 30.5%. After other income and expenses its net income was $90.6M (31.3% of revenue), so it made a profit that year.
Baylor Scott & White Heart & Vascular Hospital - Dallas is part of Baylor Scott & White Health, a health system with 23 hospitals based in Temple, TX. It is a for-profit hospital.
Baylor Scott & White Heart & Vascular Hospital - Dallas has an overall rating of 5 out of 5 stars in the official hospital quality ratings. Patients rate it 4 out of 5 stars in the patient survey.
Yes, Baylor Scott & White Heart & Vascular Hospital - Dallas provides emergency services.
568 Medicare clinicians list Baylor Scott & White Heart & Vascular Hospital - Dallas as a hospital they work at, most often in Certified Registered Nurse Anesthetist (Crna), Nurse Practitioner, Diagnostic Radiology.
In 2024, Baylor Scott & White Heart & Vascular Hospital - Dallas had 911 Medicare inpatient stays in 25 diagnosis groups. The most common was DRG 274 (percutaneous and other intracardiac procedures without mcc) with 179 stays; Medicare paid $20,922.70 per stay on average, compared with $24,748.54 across all hospitals.
In 2025, companies reported $948K in payments to Baylor Scott & White Heart & Vascular Hospital - Dallas as a teaching hospital ($30K general and $918K for research) from 7 companies.